Teladoc has released figures for the first-quarter of 2017, showing the continued growth of its telehealth services.
“During the first quarter, we achieved strong results across all our key metrics, while seamlessly onboarding over 2.6 million new lives into the Teladoc platform and growing overall utilization,” Jason Gorevic, CEO of Teladoc, said in a statement. “We continue to benefit from strong demand for both our core and new clinical offerings, resulting in our deeper integration into the virtual healthcare continuum and an enhanced value proposition to our partners. I remain very confident about our market leadership and progress towards our 2017 financial and strategic targets.”
Financial performance for the three months ended March 31, 2017 compared to the year before:
| Q1 2017 | Q1 2016 | Change | |
|---|---|---|---|
| Total revenues | $42.9M | $26.9M | 60% |
| Revenue from subscription access fees | $34.3M | $20.7M | 66% |
| Revenue from visit fees | $8.6M | $6.2M | 39% |
| Total visits | 384,839 | 239,942 | 60% |
| Gross margin | 71.7% | 70.5% | |
| Net loss | $15.7M | $15.3M | |
| Adjusted EBITDA | -$9.1M | -$11.9M |
Business outlook — guidance
| Q2 2017 | Full Year 2017 | |
|---|---|---|
| Total revenues | $44M - $45M | $180M - $185M |
| EBITDA | - $10.5M - $11.5M | - $31M - $34M |
| Adjusted EBITDA | - $6M - $7M | - $19.5M - $22.5M |
| Membership | 20.5M - 21M | 21.5M - 23M |
| Total visits | 290,000 - 310,000 | 1,400,000 - 1,450,000 |
| Net loss per share | $0.26 - $0.28 | $0.85 - $0.91 |